HighGravityDataCurrent guidance
10 items
CVS Health
Guidance from CVS Health’s last 8 earnings releases. Every value links to its sentence in the filing. See something wrong? Tell us.
Releases tracked
8
Latest release
Aug 5, 2026
Data checked
Aug 5, 2026
What changed in the Aug 5, 2026 release
Each item compared with the same item in the previous release (May 6, 2026). Values in quotation marks are the company’s words.
New — first stated in this releaseRaised / Lowered / Narrowed / Widened — changed from the prior releaseRevised — wording changed, direction not determinableChanged — value changed; the comparison couldn’t be parsed to a directionReiterated — restated unchangedNot restated — stated before, absent nowRaised and lowered describe the number, not whether the change is favorable.
| Change | Metric | Period | Previous | Now | Source |
|---|---|---|---|---|---|
| Raised | Total revenues | for FY2026 | “At least $405.0” | “At least $414.0” | Filing ↗ |
| Raised | Adjusted EPS | for FY2026 | “$7.30 to $7.50” | “$7.90 to $8.10” | Filing ↗ |
| Raised | Diluted earnings per share | for FY2026 | “$6.24-$6.44” | “$6.84-$7.04” | Filing ↗ |
| Raised | GAAP diluted EPS | for FY2026 | “$6.24 to $6.44” | “$6.84 to $7.04” | Filing ↗ |
| Raised | Cash flow from operations | for FY2026 | “at least $9.5 billion” | “at least $11.5 billion” | Filing ↗ |
Show 5 items not restated in this release
| Change | Metric | Period | Previous | Now | Source |
|---|---|---|---|---|---|
| Not restated | Net income attributable to CVS Health (GAAP measure), Per Common Share | for FY2026 | “$ 5.94” – “$ 6.14” | — | Filing ↗ |
| Not restated | Net income attributable to CVS Health (GAAP measure), Total Company | for FY2026 | “$ 7,638” – “$ 7,892” | — | Filing ↗ |
| Not restated | Adjusted income attributable to CVS Health, Per Common Share | for FY2026 | “$ 7.00” – “$ 7.20” | — | Filing ↗ |
| Not restated | Adjusted income attributable to CVS Health, Total Company | for FY2026 | “$ 8,998” – “$ 9,252” | — | Filing ↗ |
| Not restated | Weighted average diluted shares outstanding () | for FY2026 | “1,285” | — | Filing ↗ |
Current guidance
Guidance for periods that have not yet ended, at its most recent value, grouped by horizon.
Current fiscal year
| Metric | Current value | Period | Measure | First stated | Times stated | Source |
|---|---|---|---|---|---|---|
| Total revenues | “At least $414.0” | for FY2026 | GAAP-tied | May 6, 2026 | 2 | Filing ↗ |
| Adjusted EPS | “$7.90 to $8.10” | for FY2026 | Company-defined | Feb 10, 2026 | 3 | Filing ↗ |
| Diluted earnings per share | “$6.84-$7.04” | for FY2026 | GAAP-tied | May 6, 2026 | 2 | Filing ↗ |
| GAAP diluted EPS | “$6.84 to $7.04” | for FY2026 | GAAP-tied | Feb 10, 2026 | 3 | Filing ↗ |
| Net income attributable to CVS Health (GAAP measure), Per Common Share | “$ 5.94” – “$ 6.14” | for FY2026 | GAAP-tied | Feb 10, 2026 | 1 | Filing ↗ |
| Net income attributable to CVS Health (GAAP measure), Total Company | “$ 7,638” – “$ 7,892” | for FY2026 | GAAP-tied | Feb 10, 2026 | 1 | Filing ↗ |
| Adjusted income attributable to CVS Health, Per Common Share | “$ 7.00” – “$ 7.20” | for FY2026 | Company-defined | Feb 10, 2026 | 1 | Filing ↗ |
| Adjusted income attributable to CVS Health, Total Company | “$ 8,998” – “$ 9,252” | for FY2026 | Company-defined | Feb 10, 2026 | 1 | Filing ↗ |
| Cash flow from operations | “at least $11.5 billion” | for FY2026 | GAAP-tied | Feb 10, 2026 | 3 | Filing ↗ |
| Weighted average diluted shares outstanding () | “1,285” | for FY2026 | GAAP-tied | Feb 10, 2026 | 1 | Filing ↗ |
How one item moved
Adjusted EPS, for FY2025 — every statement across the year, each linked to its filing.
How your Healthcare payers & distributors sector group guides
12 companies in Healthcare payers & distributors. What they guide on, and who reported this season.
Most-guided metric families
This season’s releases
| UnitedHealth Group | Oct 13, 2026 | 5 changes |
| Cardinal Health | Aug 11, 2026 | 13 changes |
| Cencora | Aug 5, 2026 | 11 changes |
| CVS Health | Aug 5, 2026 | 5 changes |
| McKesson | Aug 5, 2026 | 1 change |
| Labcorp | Jul 30, 2026 | 2 changes |
| The Cigna Group | Jul 30, 2026 | 3 changes |
| Humana | Jul 29, 2026 | 4 changes |
Get this for your own peer set — Peer Guidance Briefing, $3,000.
Full history
Every metric, every release, eight quarters — the complete record as one table.
| Metric | FY2026 | FY2025 | FY2024 |
|---|---|---|---|
| Total revenues | 2 statements | — | — |
| Adjusted EPS | 3 statements | 4 statements | 1 statement |
| Adjusted EPS | — | 2 statements | 1 statement |
| Adjusted income attributable to CVS Health (Adjusted EPS) - Per Common Share | — | 1 statement | — |
| Diluted earnings per share | 2 statements | — | — |
The full record for CVS Health and its Healthcare payers & distributors peers, delivered as a Peer Guidance Briefing — PDF and Excel, every value linked to its filing.
Filings
The 8 earnings releases this page is built from.
| Filed | Fiscal period | Accession | Guidance items | |
|---|---|---|---|---|
| Aug 5, 2026 | FY2026 Q2 | 0000064803-26-000097 | 5 | Open filing ↗ |
| May 6, 2026 | FY2026 Q1 | 0000064803-26-000051 | 5 | Open filing ↗ |
| Feb 10, 2026 | FY2025 Q4 | 0000064803-26-000009 | 8 | Open filing ↗ |
| Oct 29, 2025 | FY2025 Q3 | 0000064803-25-000036 | 5 | Open filing ↗ |
| Jul 31, 2025 | FY2025 Q2 | 0000064803-25-000023 | 7 | Open filing ↗ |
| May 1, 2025 | FY2025 Q1 | 0000064803-25-000012 | 7 | Open filing ↗ |
| Feb 12, 2025 | FY2024 Q4 | 0000064803-25-000006 | 5 | Open filing ↗ |
| Oct 17, 2024 | FY2024 Q3 | 0001193125-24-239193 | 6 | Open filing ↗ |
Values in quotation marks are the company’s words; the classification and filing links are HighGravityData’s. HighGravityData does not score or rank companies or give investment advice.
Report an error